开立医疗
(300633)
| 流通市值：177.86亿 | | | 总市值：177.86亿 |
| 流通股本：4.31亿 | | | 总股本：4.31亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,898,798,163.94 | 1,774,621,016.57 | 1,638,710,073.63 | 1,619,051,769.22 |
| 应收票据及应收账款 | 176,834,318.23 | 174,224,263.72 | 172,175,242.44 | 214,257,529.57 |
| 其中：应收票据 | 6,691,281.48 | - | 326,486.26 | 3,200,390.71 |
| 应收账款 | 170,143,036.75 | 174,224,263.72 | 171,848,756.18 | 211,057,138.86 |
| 预付款项 | 65,565,101.71 | 55,331,152.37 | 53,833,512.28 | 51,497,461.55 |
| 其他应收款合计 | 13,255,050.55 | 11,570,420.03 | 16,713,014.36 | 7,422,222.52 |
| 存货 | 619,198,889.75 | 531,476,404.12 | 592,732,503.82 | 531,534,332.16 |
| 一年内到期的非流动资产 | 10,334,625 | 7,158,250 | 9,345,625 | 8,459,750 |
| 其他流动资产 | 24,877,273.15 | 19,624,488.71 | 14,018,872 | 12,662,365.19 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,873,808,422.33 | 2,625,395,995.52 | 2,606,668,642.53 | 2,592,025,229.21 |
| 非流动资产: | | | | |
| 长期应收款 | 9,680,896.08 | 14,458,930.24 | 11,877,950.11 | 15,206,268.19 |
| 其他权益工具投资 | 8,202,777 | 8,202,777 | 8,202,777 | 8,202,777 |
| 固定资产 | 420,817,990.4 | 419,545,760.99 | 391,670,122.39 | 382,986,677.17 |
| 在建工程 | 252,248,017.67 | 254,203,561.52 | 223,621,317.49 | 202,791,284.02 |
| 使用权资产 | 44,096,960.82 | 46,145,493.51 | 33,133,166.25 | 34,697,840.64 |
| 无形资产 | 164,622,632.96 | 164,854,790.33 | 163,394,800.78 | 165,500,854.87 |
| 商誉 | 165,899,049.19 | 165,899,049.19 | 183,648,081.33 | 184,744,571.96 |
| 长期待摊费用 | 35,572,250.25 | 17,929,077.74 | 12,962,966.42 | 12,520,558.8 |
| 递延所得税资产 | 28,761,877.82 | 30,601,841.92 | 35,493,598.73 | 38,661,546.85 |
| 其他非流动资产 | 39,943,415.6 | 24,179,816.87 | 42,749,223.03 | 55,404,564.19 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,169,845,867.79 | 1,146,021,099.31 | 1,106,754,003.53 | 1,100,716,943.69 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,043,654,290.12 | 3,771,417,094.83 | 3,713,422,646.06 | 3,692,742,172.9 |
| 流动负债: | | | | |
| 短期借款 | 249,990,088.94 | 23,628,320.07 | 104,240,583.33 | 154,361,416.67 |
| 交易性金融负债 | 2,006,568.71 | 1,565,542.46 | 11,963,153.91 | 18,625,012.05 |
| 应付票据及应付账款 | 226,897,470.24 | 186,145,110.95 | 196,902,201.13 | 192,028,513.82 |
| 其中：应付票据 | - | - | 4,043,486.04 | 1,326,028.9 |
| 应付账款 | 226,897,470.24 | 186,145,110.95 | 192,858,715.09 | 190,702,484.92 |
| 合同负债 | 46,346,122.68 | 44,592,473.23 | 56,189,265.08 | 55,291,536.78 |
| 应付职工薪酬 | 99,296,976.82 | 170,492,881.54 | 116,264,701.86 | 97,377,923.65 |
| 应交税费 | 24,204,949.56 | 38,891,638.12 | 38,890,914.99 | 43,115,868.06 |
| 其他应付款合计 | 67,666,041.92 | 82,900,707.78 | 63,468,193.61 | 63,453,070.74 |
| 一年内到期的非流动负债 | 13,594,159.69 | 14,808,514.68 | 8,313,073.49 | 11,394,081.77 |
| 其他流动负债 | 1,631,655.97 | 5,599,709.45 | 3,691,823.48 | 3,661,073.71 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 731,634,034.53 | 568,624,898.28 | 599,923,910.88 | 639,308,497.25 |
| 非流动负债: | | | | |
| 租赁负债 | 32,419,721.28 | 34,007,440.07 | 26,646,691.63 | 25,481,985.83 |
| 递延收益 | 23,252,141.59 | 22,831,105.2 | 26,725,540.62 | 27,064,121.82 |
| 递延所得税负债 | - | - | 790,829.47 | 838,524.64 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 55,671,862.87 | 56,838,545.27 | 54,163,061.72 | 53,384,632.29 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 787,305,897.4 | 625,463,443.55 | 654,086,972.6 | 692,693,129.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 432,550,255 | 430,652,785 | 430,652,785 | 430,652,785 |
| 资本公积 | 1,157,483,836.45 | 1,118,989,432.68 | 1,104,240,704.06 | 1,097,713,344.8 |
| 减:库存股 | 91,842,579.23 | 59,992,347.23 | - | - |
| 其他综合收益 | 25,444,014.12 | 23,781,742.08 | 25,786,271.35 | 20,584,302.81 |
| 盈余公积 | 203,824,055.73 | 203,824,055.73 | 153,612,731.38 | 153,612,731.38 |
| 未分配利润 | 1,528,888,810.65 | 1,428,697,983.02 | 1,345,043,181.67 | 1,297,485,879.37 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,256,348,392.72 | 3,145,953,651.28 | 3,059,335,673.46 | 3,000,049,043.36 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,256,348,392.72 | 3,145,953,651.28 | 3,059,335,673.46 | 3,000,049,043.36 |
| 负债和股东权益合计 | 4,043,654,290.12 | 3,771,417,094.83 | 3,713,422,646.06 | 3,692,742,172.9 |
| 公告日期 | 2024-04-27 | 2024-04-12 | 2023-10-26 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |